[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

[$rgnx](/topic/$rgnx)

### Sentiment: XXX%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$rgnx/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$rgnx/time-series/sentiment.tsv)  
**Current Value**: XXX%  
**Daily Average**: XX%  
**1 Week**: XXX% +50%  
**1 Month**: XXX% +50%  
**1-Year High**: XXX% on 2025-04-27  
**1-Year Low**: XX% on 2025-09-11  

**Most Supportive Themes**
- **Positive Clinical Trial Data and Presentations:** (40%) Positive news regarding clinical trial data and upcoming presentations is driving positive sentiment.
- **Analyst Reports and Recommendations:** (30%) Reports from analysts, particularly those from major financial institutions, are highlighting positive aspects of the company.
- **Mentions in Broader Biotech Discussions:** (20%) The stock is being mentioned in discussions about the biotech sector, often alongside other promising companies.
  
**Most Critical Themes**
- **FDA Review Extension:** (10%)  The FDA review extension for RGX-121 raises some concerns, despite no safety issues being reported.
  
Network engagement breakdown:  
| Network | Positive | %   | Neutral | %   | Negative | %  |
| ------- | -------- | -   | ------- | -   | -------- | -  |
| X       | XXX      | XX% | XXX     | XX% | X        | X% |
|         |          |     |         |     |          |    |
| Total   | XXX      | XX% | XXX     | XX% | X        | X% |